Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.050 PosttranslationalModification group BEFREE Thus, our objectives were to assess the status of p16 ink4a methylation and the HPV16 E1/E2 integrity in samples in different stages of cervical diseases. 30569945 2018
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.050 GeneticVariation group BEFREE In the present study, we investigated for the impact of p16 genotypes/haplotypes on patients' vulnerability to cervical disease and examined whether these factors can be used as progression markers in the Greek population. 29168898 2018
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.050 Biomarker group BEFREE The keywords hrHPV, p16INK4a gene, and uterine cervical disease (MeSH terms) were used. 27443891 2016
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.050 Biomarker group BEFREE Conclusively, HPV load, p16(INK4A) , and GLUT1 can be instrumental in predicting the severity of HPV-related cervical disease. 24020724 2014
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.050 Biomarker group BEFREE The authors compared the ability of p16(INK4a) and HR HPV detection by Hybrid Capture 2 (HC2) to detect the presence of significant cervical disease.METHODS. 17078096 2006
Entrez Id: 57026
Gene Symbol: PDXP
PDXP
0.030 AlteredExpression group BEFREE The mean age of women undergoing local treatment for pre-invasive cervical disease (cervical intra-epithelial neoplasia; CIN) or early cervical cancer (stage IA1) is around their 30s and similar to the age of women having their first child. 29095502 2017
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.030 GeneticVariation group BEFREE We also examined whether the presence of specific p53 genotypes in combination with HPV16 variants or E6 T350G sequence variation can modify an individual's susceptibility to cervical disease.<b>Methodology.</b> The analysis of p53 genotypes was performed through PCR-RFLP. 28857739 2017
Entrez Id: 57026
Gene Symbol: PDXP
PDXP
0.030 Biomarker group BEFREE We conclude that the TERC gain seems to be an important associated genetic event in CIN and carcinoma; FISH is a potential tool for the diagnoses of uterine cervix disease. 20009881 2009
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.030 GeneticVariation group BEFREE Our data do not support the hypothesis that this p53 polymorphism is involved in the development of high-grade squamous cervical disease in this population. 10449610 1999
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.030 Biomarker group BEFREE Our findings indicate that there is a statistically significant, inverse association between the presence of p53 and invasive cervical disease [odds ratio (OR), 0.3; 95% confidence interval (CI), 0.1-0.7]. 9162297 1996
Entrez Id: 57026
Gene Symbol: PDXP
PDXP
0.030 GeneticVariation group BEFREE The polymerase chain reaction (PCR) has been used to amplify the long control region (LCR) of episomal human papillomavirus type 16 from cervical scrape DNA obtained from a woman with no evidence of cervical disease and a woman with cervical intraepithelial neoplasia grade 3 (CIN 3). 8388023 1993
Entrez Id: 3811
Gene Symbol: KIR3DL1
KIR3DL1
0.020 Biomarker group BEFREE Although no relationship was found between KIR genes and HPV-related cervical disease, a significant relationship was found between HLA-C alleles as ligands of KIR and HPV-related cervical disease. 23398510 2013
Entrez Id: 2669
Gene Symbol: GEM
GEM
0.020 Biomarker group BEFREE Although no relationship was found between KIR genes and HPV-related cervical disease, a significant relationship was found between HLA-C alleles as ligands of KIR and HPV-related cervical disease. 23398510 2013
Entrez Id: 2669
Gene Symbol: GEM
GEM
0.020 GeneticVariation group BEFREE The aim of this study was to investigate the association of polymorphic immune response genes, namely KIR, HLA class I and II, and single-nucleotide polymorphisms (SNPs) of cytokines with HPV-related cervical disease. 23936772 2013
Entrez Id: 3811
Gene Symbol: KIR3DL1
KIR3DL1
0.020 GeneticVariation group BEFREE The aim of this study was to investigate the association of polymorphic immune response genes, namely KIR, HLA class I and II, and single-nucleotide polymorphisms (SNPs) of cytokines with HPV-related cervical disease. 23936772 2013
Entrez Id: 60489
Gene Symbol: APOBEC3G
APOBEC3G
0.010 Biomarker group BEFREE BACKGROUND We studied the effect of APOBEC3G on persistent human papillomavirus (HPV) infection and the correlation between APOBEC3G polymorphism and HPV persistent infection and cervical disease progression in Uygur women in China. 31527570 2019
Entrez Id: 429
Gene Symbol: ASCL1
ASCL1
0.010 AlteredExpression group BEFREE Hypermethylation levels of ASCL1, LHX8 and ST6GALNAC5 increased with severity of cervical disease. 30101434 2018
Entrez Id: 4594
Gene Symbol: MMUT
MMUT
0.010 Biomarker group BEFREE Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples. 30218891 2018
Entrez Id: 81849
Gene Symbol: ST6GALNAC5
ST6GALNAC5
0.010 Biomarker group BEFREE Hypermethylation levels of ASCL1, LHX8 and ST6GALNAC5 increased with severity of cervical disease. 30101434 2018
Entrez Id: 5925
Gene Symbol: RB1
RB1
0.010 GeneticVariation group BEFREE The present analysis investigated the prevalence of the nucleotide polymorphism A153104G, which is located at intron 18 of the RB1 gene, and investigated the impact of the polymorphic variability in the exon 19 and its flanking intronic sequences on the severity of cervical disease in HPV16-positive Greek women. 30303478 2018
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.010 GeneticVariation group BEFREE In the present study, we investigated for the impact of p16 genotypes/haplotypes on patients' vulnerability to cervical disease and examined whether these factors can be used as progression markers in the Greek population. 29168898 2018
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.010 Biomarker group BEFREE Risk stratification of cervical disease using detection of human papillomavirus (HPV) E4 protein and cellular MCM protein in clinical liquid based cytology samples. 30218891 2018
Entrez Id: 407040
Gene Symbol: MIR34A
MIR34A
0.010 AlteredExpression group BEFREE There was a trend toward an increasing amplification of hTERC with the increasing severity of cervical lesions. miR-21-5p and miR-34a expression, and hTERC amplification were more specific than HPV positivity in differentiating low-grade cervical disorders from high-grade ones (P < 0.05). 29487007 2018
Entrez Id: 431707
Gene Symbol: LHX8
LHX8
0.010 AlteredExpression group BEFREE Hypermethylation levels of ASCL1, LHX8 and ST6GALNAC5 increased with severity of cervical disease. 30101434 2018
Entrez Id: 1299
Gene Symbol: COL9A3
COL9A3
0.010 Biomarker group BEFREE This study examined Korean health insurance review and assessment service (HIRA) claims data to the aim of assessing prevalence and comparing current medical practice and costs of cervical disorders in Korea.Current practice trends were determined through assessment of prevalence, total expenses, per-patient expense, average days in care, average days of visits, sociodemographic characteristics, distribution of medical costs, and frequency of treatment types of high frequency cervical disorders (cervical sprain/strain, cervical intervertebral disc displacement [IDD], and cervicalgia).Although the number of cervical IDD patients was few, total expenses, per-patient expense, average days in care, and average days of visits were highest. 29145327 2017